Global Cancer Biological Therapy Market Insights and Forecast to 2031

Report ID: 1156312 | Published Date: Jan 2025 | No. of Page: 112 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cancer Biological Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Monoclonal Antibodies
        1.2.3 Vaccines
        1.2.4 Cancer Growth Blockers
        1.2.5 Blood Cell Growth Factors
    1.3 Market by Application
        1.3.1 Global Cancer Biological Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Diagnostic Laboratories
        1.3.4 Research & Academic Laboratories
        1.3.5 Pharmaceutical & Biotechnology Companies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Cancer Biological Therapy Market Perspective (2017-2028)
    2.2 Cancer Biological Therapy Growth Trends by Region
        2.2.1 Cancer Biological Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Cancer Biological Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Cancer Biological Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Cancer Biological Therapy Market Dynamics
        2.3.1 Cancer Biological Therapy Industry Trends
        2.3.2 Cancer Biological Therapy Market Drivers
        2.3.3 Cancer Biological Therapy Market Challenges
        2.3.4 Cancer Biological Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cancer Biological Therapy Players by Revenue
        3.1.1 Global Top Cancer Biological Therapy Players by Revenue (2017-2022)
        3.1.2 Global Cancer Biological Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Cancer Biological Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cancer Biological Therapy Revenue
    3.4 Global Cancer Biological Therapy Market Concentration Ratio
        3.4.1 Global Cancer Biological Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cancer Biological Therapy Revenue in 2021
    3.5 Cancer Biological Therapy Key Players Head office and Area Served
    3.6 Key Players Cancer Biological Therapy Product Solution and Service
    3.7 Date of Enter into Cancer Biological Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Biological Therapy Breakdown Data by Type
    4.1 Global Cancer Biological Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Cancer Biological Therapy Forecasted Market Size by Type (2023-2028)
5 Cancer Biological Therapy Breakdown Data by Application
    5.1 Global Cancer Biological Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Cancer Biological Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Cancer Biological Therapy Market Size (2017-2028)
    6.2 North America Cancer Biological Therapy Market Size by Type
        6.2.1 North America Cancer Biological Therapy Market Size by Type (2017-2022)
        6.2.2 North America Cancer Biological Therapy Market Size by Type (2023-2028)
        6.2.3 North America Cancer Biological Therapy Market Share by Type (2017-2028)
    6.3 North America Cancer Biological Therapy Market Size by Application
        6.3.1 North America Cancer Biological Therapy Market Size by Application (2017-2022)
        6.3.2 North America Cancer Biological Therapy Market Size by Application (2023-2028)
        6.3.3 North America Cancer Biological Therapy Market Share by Application (2017-2028)
    6.4 North America Cancer Biological Therapy Market Size by Country
        6.4.1 North America Cancer Biological Therapy Market Size by Country (2017-2022)
        6.4.2 North America Cancer Biological Therapy Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Cancer Biological Therapy Market Size (2017-2028)
    7.2 Europe Cancer Biological Therapy Market Size by Type
        7.2.1 Europe Cancer Biological Therapy Market Size by Type (2017-2022)
        7.2.2 Europe Cancer Biological Therapy Market Size by Type (2023-2028)
        7.2.3 Europe Cancer Biological Therapy Market Share by Type (2017-2028)
    7.3 Europe Cancer Biological Therapy Market Size by Application
        7.3.1 Europe Cancer Biological Therapy Market Size by Application (2017-2022)
        7.3.2 Europe Cancer Biological Therapy Market Size by Application (2023-2028)
        7.3.3 Europe Cancer Biological Therapy Market Share by Application (2017-2028)
    7.4 Europe Cancer Biological Therapy Market Size by Country
        7.4.1 Europe Cancer Biological Therapy Market Size by Country (2017-2022)
        7.4.2 Europe Cancer Biological Therapy Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cancer Biological Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Cancer Biological Therapy Market Size by Type
        8.2.1 Asia-Pacific Cancer Biological Therapy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Cancer Biological Therapy Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Cancer Biological Therapy Market Share by Type (2017-2028)
    8.3 Asia-Pacific Cancer Biological Therapy Market Size by Application
        8.3.1 Asia-Pacific Cancer Biological Therapy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Cancer Biological Therapy Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Cancer Biological Therapy Market Share by Application (2017-2028)
    8.4 Asia-Pacific Cancer Biological Therapy Market Size by Region
        8.4.1 Asia-Pacific Cancer Biological Therapy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Cancer Biological Therapy Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Cancer Biological Therapy Market Size (2017-2028)
    9.2 Latin America Cancer Biological Therapy Market Size by Type
        9.2.1 Latin America Cancer Biological Therapy Market Size by Type (2017-2022)
        9.2.2 Latin America Cancer Biological Therapy Market Size by Type (2023-2028)
        9.2.3 Latin America Cancer Biological Therapy Market Share by Type (2017-2028)
    9.3 Latin America Cancer Biological Therapy Market Size by Application
        9.3.1 Latin America Cancer Biological Therapy Market Size by Application (2017-2022)
        9.3.2 Latin America Cancer Biological Therapy Market Size by Application (2023-2028)
        9.3.3 Latin America Cancer Biological Therapy Market Share by Application (2017-2028)
    9.4 Latin America Cancer Biological Therapy Market Size by Country
        9.4.1 Latin America Cancer Biological Therapy Market Size by Country (2017-2022)
        9.4.2 Latin America Cancer Biological Therapy Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cancer Biological Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Cancer Biological Therapy Market Size by Type
        10.2.1 Middle East & Africa Cancer Biological Therapy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Cancer Biological Therapy Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Cancer Biological Therapy Market Share by Type (2017-2028)
    10.3 Middle East & Africa Cancer Biological Therapy Market Size by Application
        10.3.1 Middle East & Africa Cancer Biological Therapy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Cancer Biological Therapy Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Cancer Biological Therapy Market Share by Application (2017-2028)
    10.4 Middle East & Africa Cancer Biological Therapy Market Size by Country
        10.4.1 Middle East & Africa Cancer Biological Therapy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Cancer Biological Therapy Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 ELI Lilly
        11.1.1 ELI Lilly Company Details
        11.1.2 ELI Lilly Business Overview
        11.1.3 ELI Lilly Cancer Biological Therapy Introduction
        11.1.4 ELI Lilly Revenue in Cancer Biological Therapy Business (2017-2022)
        11.1.5 ELI Lilly Recent Developments
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Cancer Biological Therapy Introduction
        11.2.4 Sanofi Revenue in Cancer Biological Therapy Business (2017-2022)
        11.2.5 Sanofi Recent Developments
    11.3 Merck
        11.3.1 Merck Company Details
        11.3.2 Merck Business Overview
        11.3.3 Merck Cancer Biological Therapy Introduction
        11.3.4 Merck Revenue in Cancer Biological Therapy Business (2017-2022)
        11.3.5 Merck Recent Developments
    11.4 Bayer
        11.4.1 Bayer Company Details
        11.4.2 Bayer Business Overview
        11.4.3 Bayer Cancer Biological Therapy Introduction
        11.4.4 Bayer Revenue in Cancer Biological Therapy Business (2017-2022)
        11.4.5 Bayer Recent Developments
    11.5 Roche
        11.5.1 Roche Company Details
        11.5.2 Roche Business Overview
        11.5.3 Roche Cancer Biological Therapy Introduction
        11.5.4 Roche Revenue in Cancer Biological Therapy Business (2017-2022)
        11.5.5 Roche Recent Developments
    11.6 Novartis International
        11.6.1 Novartis International Company Details
        11.6.2 Novartis International Business Overview
        11.6.3 Novartis International Cancer Biological Therapy Introduction
        11.6.4 Novartis International Revenue in Cancer Biological Therapy Business (2017-2022)
        11.6.5 Novartis International Recent Developments
    11.7 Pfizer
        11.7.1 Pfizer Company Details
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer Cancer Biological Therapy Introduction
        11.7.4 Pfizer Revenue in Cancer Biological Therapy Business (2017-2022)
        11.7.5 Pfizer Recent Developments
    11.8 Bristol-Myers Squibb
        11.8.1 Bristol-Myers Squibb Company Details
        11.8.2 Bristol-Myers Squibb Business Overview
        11.8.3 Bristol-Myers Squibb Cancer Biological Therapy Introduction
        11.8.4 Bristol-Myers Squibb Revenue in Cancer Biological Therapy Business (2017-2022)
        11.8.5 Bristol-Myers Squibb Recent Developments
    11.9 Seattle Genetics
        11.9.1 Seattle Genetics Company Details
        11.9.2 Seattle Genetics Business Overview
        11.9.3 Seattle Genetics Cancer Biological Therapy Introduction
        11.9.4 Seattle Genetics Revenue in Cancer Biological Therapy Business (2017-2022)
        11.9.5 Seattle Genetics Recent Developments
    11.10 Amgen
        11.10.1 Amgen Company Details
        11.10.2 Amgen Business Overview
        11.10.3 Amgen Cancer Biological Therapy Introduction
        11.10.4 Amgen Revenue in Cancer Biological Therapy Business (2017-2022)
        11.10.5 Amgen Recent Developments
    11.11 Takeda Pharmaceuticals
        11.11.1 Takeda Pharmaceuticals Company Details
        11.11.2 Takeda Pharmaceuticals Business Overview
        11.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Introduction
        11.11.4 Takeda Pharmaceuticals Revenue in Cancer Biological Therapy Business (2017-2022)
        11.11.5 Takeda Pharmaceuticals Recent Developments
    11.12 GlaxoSmithKline
        11.12.1 GlaxoSmithKline Company Details
        11.12.2 GlaxoSmithKline Business Overview
        11.12.3 GlaxoSmithKline Cancer Biological Therapy Introduction
        11.12.4 GlaxoSmithKline Revenue in Cancer Biological Therapy Business (2017-2022)
        11.12.5 GlaxoSmithKline Recent Developments
    11.13 Spectrum Pharmaceuticals
        11.13.1 Spectrum Pharmaceuticals Company Details
        11.13.2 Spectrum Pharmaceuticals Business Overview
        11.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Introduction
        11.13.4 Spectrum Pharmaceuticals Revenue in Cancer Biological Therapy Business (2017-2022)
        11.13.5 Spectrum Pharmaceuticals Recent Developments
    11.14 Celgene Corporation
        11.14.1 Celgene Corporation Company Details
        11.14.2 Celgene Corporation Business Overview
        11.14.3 Celgene Corporation Cancer Biological Therapy Introduction
        11.14.4 Celgene Corporation Revenue in Cancer Biological Therapy Business (2017-2022)
        11.14.5 Celgene Corporation Recent Developments
    11.15 AstraZeneca, Plc.
        11.15.1 AstraZeneca, Plc. Company Details
        11.15.2 AstraZeneca, Plc. Business Overview
        11.15.3 AstraZeneca, Plc. Cancer Biological Therapy Introduction
        11.15.4 AstraZeneca, Plc. Revenue in Cancer Biological Therapy Business (2017-2022)
        11.15.5 AstraZeneca, Plc. Recent Developments
    11.16 Otsuka
        11.16.1 Otsuka Company Details
        11.16.2 Otsuka Business Overview
        11.16.3 Otsuka Cancer Biological Therapy Introduction
        11.16.4 Otsuka Revenue in Cancer Biological Therapy Business (2017-2022)
        11.16.5 Otsuka Recent Developments
    11.17 Eisai
        11.17.1 Eisai Company Details
        11.17.2 Eisai Business Overview
        11.17.3 Eisai Cancer Biological Therapy Introduction
        11.17.4 Eisai Revenue in Cancer Biological Therapy Business (2017-2022)
        11.17.5 Eisai Recent Developments
    11.18 Abbvie
        11.18.1 Abbvie Company Details
        11.18.2 Abbvie Business Overview
        11.18.3 Abbvie Cancer Biological Therapy Introduction
        11.18.4 Abbvie Revenue in Cancer Biological Therapy Business (2017-2022)
        11.18.5 Abbvie Recent Developments
    11.19 Incyte
        11.19.1 Incyte Company Details
        11.19.2 Incyte Business Overview
        11.19.3 Incyte Cancer Biological Therapy Introduction
        11.19.4 Incyte Revenue in Cancer Biological Therapy Business (2017-2022)
        11.19.5 Incyte Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Cancer Biological Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Monoclonal Antibodies
    Table 3. Key Players of Vaccines
    Table 4. Key Players of Cancer Growth Blockers
    Table 5. Key Players of Blood Cell Growth Factors
    Table 6. Global Cancer Biological Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Cancer Biological Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Cancer Biological Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Cancer Biological Therapy Market Share by Region (2017-2022)
    Table 10. Global Cancer Biological Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Cancer Biological Therapy Market Share by Region (2023-2028)
    Table 12. Cancer Biological Therapy Market Trends
    Table 13. Cancer Biological Therapy Market Drivers
    Table 14. Cancer Biological Therapy Market Challenges
    Table 15. Cancer Biological Therapy Market Restraints
    Table 16. Global Cancer Biological Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Cancer Biological Therapy Revenue Share by Players (2017-2022)
    Table 18. Global Top Cancer Biological Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biological Therapy as of 2021)
    Table 19. Ranking of Global Top Cancer Biological Therapy Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Cancer Biological Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Cancer Biological Therapy Product Solution and Service
    Table 23. Date of Enter into Cancer Biological Therapy Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Cancer Biological Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Cancer Biological Therapy Revenue Market Share by Type (2017-2022)
    Table 27. Global Cancer Biological Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Cancer Biological Therapy Revenue Market Share by Type (2023-2028)
    Table 29. Global Cancer Biological Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Cancer Biological Therapy Revenue Share by Application (2017-2022)
    Table 31. Global Cancer Biological Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Cancer Biological Therapy Revenue Share by Application (2023-2028)
    Table 33. North America Cancer Biological Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Cancer Biological Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Cancer Biological Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Cancer Biological Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Cancer Biological Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Cancer Biological Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Cancer Biological Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Cancer Biological Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Cancer Biological Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Cancer Biological Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Cancer Biological Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Cancer Biological Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Cancer Biological Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Cancer Biological Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Cancer Biological Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Cancer Biological Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Cancer Biological Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Cancer Biological Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Cancer Biological Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Cancer Biological Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Cancer Biological Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Cancer Biological Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Cancer Biological Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Cancer Biological Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Cancer Biological Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Cancer Biological Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Cancer Biological Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Cancer Biological Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Cancer Biological Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Cancer Biological Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 63. ELI Lilly Company Details
    Table 64. ELI Lilly Business Overview
    Table 65. ELI Lilly Cancer Biological Therapy Product
    Table 66. ELI Lilly Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 67. ELI Lilly Recent Developments
    Table 68. Sanofi Company Details
    Table 69. Sanofi Business Overview
    Table 70. Sanofi Cancer Biological Therapy Product
    Table 71. Sanofi Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 72. Sanofi Recent Developments
    Table 73. Merck Company Details
    Table 74. Merck Business Overview
    Table 75. Merck Cancer Biological Therapy Product
    Table 76. Merck Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 77. Merck Recent Developments
    Table 78. Bayer Company Details
    Table 79. Bayer Business Overview
    Table 80. Bayer Cancer Biological Therapy Product
    Table 81. Bayer Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 82. Bayer Recent Developments
    Table 83. Roche Company Details
    Table 84. Roche Business Overview
    Table 85. Roche Cancer Biological Therapy Product
    Table 86. Roche Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 87. Roche Recent Developments
    Table 88. Novartis International Company Details
    Table 89. Novartis International Business Overview
    Table 90. Novartis International Cancer Biological Therapy Product
    Table 91. Novartis International Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 92. Novartis International Recent Developments
    Table 93. Pfizer Company Details
    Table 94. Pfizer Business Overview
    Table 95. Pfizer Cancer Biological Therapy Product
    Table 96. Pfizer Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 97. Pfizer Recent Developments
    Table 98. Bristol-Myers Squibb Company Details
    Table 99. Bristol-Myers Squibb Business Overview
    Table 100. Bristol-Myers Squibb Cancer Biological Therapy Product
    Table 101. Bristol-Myers Squibb Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 102. Bristol-Myers Squibb Recent Developments
    Table 103. Seattle Genetics Company Details
    Table 104. Seattle Genetics Business Overview
    Table 105. Seattle Genetics Cancer Biological Therapy Product
    Table 106. Seattle Genetics Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 107. Seattle Genetics Recent Developments
    Table 108. Amgen Company Details
    Table 109. Amgen Business Overview
    Table 110. Amgen Cancer Biological Therapy Product
    Table 111. Amgen Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 112. Amgen Recent Developments
    Table 113. Takeda Pharmaceuticals Company Details
    Table 114. Takeda Pharmaceuticals Business Overview
    Table 115. Takeda Pharmaceuticals Cancer Biological Therapy Product
    Table 116. Takeda Pharmaceuticals Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 117. Takeda Pharmaceuticals Recent Developments
    Table 118. GlaxoSmithKline Company Details
    Table 119. GlaxoSmithKline Business Overview
    Table 120. GlaxoSmithKline Cancer Biological Therapy Product
    Table 121. GlaxoSmithKline Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 122. GlaxoSmithKline Recent Developments
    Table 123. Spectrum Pharmaceuticals Company Details
    Table 124. Spectrum Pharmaceuticals Business Overview
    Table 125. Spectrum Pharmaceuticals Cancer Biological Therapy Product
    Table 126. Spectrum Pharmaceuticals Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 127. Spectrum Pharmaceuticals Recent Developments
    Table 128. Celgene Corporation Company Details
    Table 129. Celgene Corporation Business Overview
    Table 130. Celgene Corporation Cancer Biological Therapy Product
    Table 131. Celgene Corporation Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 132. Celgene Corporation Recent Developments
    Table 133. AstraZeneca, Plc. Company Details
    Table 134. AstraZeneca, Plc. Business Overview
    Table 135. AstraZeneca, Plc. Cancer Biological Therapy Product
    Table 136. AstraZeneca, Plc. Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 137. AstraZeneca, Plc. Recent Developments
    Table 138. Otsuka Company Details
    Table 139. Otsuka Business Overview
    Table 140. Otsuka Cancer Biological Therapy Product
    Table 141. Otsuka Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 142. Otsuka Recent Developments
    Table 143. Eisai Company Details
    Table 144. Eisai Business Overview
    Table 145. Eisai Cancer Biological Therapy Product
    Table 146. Eisai Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 147. Eisai Recent Developments
    Table 148. Abbvie Company Details
    Table 149. Abbvie Business Overview
    Table 150. Abbvie Cancer Biological Therapy Product
    Table 151. Abbvie Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 152. Abbvie Recent Developments
    Table 153. Incyte Company Details
    Table 154. Incyte Business Overview
    Table 155. Incyte Cancer Biological Therapy Product
    Table 156. Incyte Revenue in Cancer Biological Therapy Business (2017-2022) & (US$ Million)
    Table 157. Incyte Recent Developments
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Biological Therapy Market Share by Type: 2021 VS 2028
    Figure 2. Monoclonal Antibodies Features
    Figure 3. Vaccines Features
    Figure 4. Cancer Growth Blockers Features
    Figure 5. Blood Cell Growth Factors Features
    Figure 6. Global Cancer Biological Therapy Market Share by Application: 2021 VS 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Diagnostic Laboratories Case Studies
    Figure 9. Research & Academic Laboratories Case Studies
    Figure 10. Pharmaceutical & Biotechnology Companies Case Studies
    Figure 11. Cancer Biological Therapy Report Years Considered
    Figure 12. Global Cancer Biological Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Cancer Biological Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Cancer Biological Therapy Market Share by Region: 2021 VS 2028
    Figure 15. Global Cancer Biological Therapy Market Share by Players in 2021
    Figure 16. Global Top Cancer Biological Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biological Therapy as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Cancer Biological Therapy Revenue in 2021
    Figure 18. North America Cancer Biological Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Cancer Biological Therapy Market Size Market Share by Type (2017-2028)
    Figure 20. North America Cancer Biological Therapy Market Size Market Share by Application (2017-2028)
    Figure 21. North America Cancer Biological Therapy Market Size Share by Country (2017-2028)
    Figure 22. United States Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Cancer Biological Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Cancer Biological Therapy Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Cancer Biological Therapy Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Cancer Biological Therapy Market Size Share by Country (2017-2028)
    Figure 28. Germany Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Cancer Biological Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Cancer Biological Therapy Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Cancer Biological Therapy Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Cancer Biological Therapy Market Size Share by Region (2017-2028)
    Figure 38. China Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Latin America Cancer Biological Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Cancer Biological Therapy Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Cancer Biological Therapy Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Cancer Biological Therapy Market Size Share by Country (2017-2028)
    Figure 48. Mexico Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Cancer Biological Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Cancer Biological Therapy Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Cancer Biological Therapy Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Cancer Biological Therapy Market Size Share by Country (2017-2028)
    Figure 54. Turkey Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Cancer Biological Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. ELI Lilly Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 58. Sanofi Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 59. Merck Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 60. Bayer Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 61. Roche Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 62. Novartis International Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 63. Pfizer Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 65. Seattle Genetics Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 66. Amgen Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 67. Takeda Pharmaceuticals Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 68. GlaxoSmithKline Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 69. Spectrum Pharmaceuticals Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 70. Celgene Corporation Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 71. AstraZeneca, Plc. Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 72. Otsuka Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 73. Eisai Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 74. Abbvie Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 75. Incyte Revenue Growth Rate in Cancer Biological Therapy Business (2017-2022)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ELI Lilly
Sanofi
Merck
Bayer
Roche
Novartis International
Pfizer
Bristol-Myers Squibb
Seattle Genetics
Amgen
Takeda Pharmaceuticals
GlaxoSmithKline
Spectrum Pharmaceuticals
Celgene Corporation
AstraZeneca, Plc.
Otsuka
Eisai
Abbvie
Incyte
Frequently Asked Questions
Cancer Biological Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Biological Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Biological Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

2D Chromatography

2D Chromatography market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More

Calcium Phosphate

Calcium Phosphate market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More